市場調查報告書
商品編碼
1438128
2030 年眼科包裝市場預測:按產品、類型、劑量、原料、最終用戶和地區進行的全球分析Ophthalmic Packaging Market Forecasts to 2030 - Global Analysis By Product (Plastic Droptainer Bottles, Glass Dropper Bottles, Metal Collapsible Tubes, Plastic Collapsible Tubes and Other Products), Type, Dose, Raw Material, End User and By Geography |
根據Stratistics MRC預測,2023年全球眼科包裝市場規模將達115億美元,預計2030年將達到231億美元,預測期內複合年成長率為10.4%。
眼科包裝在敏感眼科藥物的保護和輸送中發揮重要作用。這些專用包裝經過精確、精心設計,考慮到無菌、準確性和易用性等因素。通常,眼科包裝使用符合監管標準的材料,以確保無菌和密封並保持產品的有效性。清晰的標籤有助於正確使用,防篡改功能可增強消費者的信心。包裝的人體工學設計優先考慮使用者的便利性,並有利於分配和儲存。
根據美國一般人口橫斷面調查(2018年),約有16.7至5020萬美國患有乾眼症,佔總人口的5%至15%。
與眼睛相關的疾病和病症增加
隨著白內障和青光眼等疾病在全球範圍內患病率的增加,對確保眼科產品安全、有效和正確劑量的專用包裝的需求不斷成長。這推動了包裝設計的創新,融合了先進的藥物輸送系統和防篡改措施等功能。對遵守嚴格監管標準的需求日益成長,以及對消費者友好和方便的包裝的重視,進一步推動了眼科包裝市場的發展。
保存期限有限
包裝解決方案必須確保產品穩定性並防止短期內劣化,從而增加複雜性和成本。製造商面臨著滿足嚴格要求以保持敏感配方有效性的挑戰。保存期限短需要快速生產和分銷,從而增加了營運成本。此外,頻繁的產品變化會對庫存管理造成壓力。這種限制不僅限制了包裝設計的彈性,而且阻礙了成本效益並影響了報酬率。
提高消費者對眼睛健康的認知
意識的提高促使消費者優先考慮眼睛護理,從而導致對眼科產品的需求激增。因此,包裝透過確保產品的安全性、有效性和便利性,在贏得和保留客戶方面發揮著至關重要的作用。品牌被迫投資於具有視覺吸引力和資訊豐富的包裝,以傳達眼部護理產品的好處,建立消費者信任並推動市場成長。
由於競爭激烈,原料的供應情況
滿足嚴格的監管要求需要進行大量的測試、記錄並遵守複雜的準則,從而增加了開發和生產成本。這對於中小企業來說尤其是負擔,並可能阻礙他們進入市場的能力。需要不斷更新以符合不斷變化的法規,這進一步加劇了資源的緊張。此外,嚴格的標準會限制彈性和創新,阻礙市場成長,因為公司優先考慮合規性而不是探索新穎的包裝解決方案。
COVID-19 的影響
鎖門、旅行限制和消費者優先事項的變化正在減少對非必需品(包括某些眼部護理產品)的需求。此外,醫療保健資源集中在與流行病相關的問題上,轉移了人們對常規眼部保健的注意力。這些因素綜合在一起,導致眼科包裝市場暫時低迷。
塑膠容器領域預計將在預測期內成為最大的領域
塑膠容器重量輕且耐用,為眼藥水提供安全的環境,保護眼藥水免受污染並保持功效。塑膠容器的採用提高了眼科產品的易用性並延長了保存期限。此外,成本效益和易於製造也促進了市場的成長。
預計眼霜細分市場在預測期內複合年成長率最高
預計眼霜細分市場在預測期內將出現最高的複合年成長率。隨著這些配方在治療和化妝品應用中越來越受歡迎,包裝要求也在不斷變化。對確保產品完整性和用戶便利性的創新包裝解決方案的需求正在迅速成長。製造商越來越注重易於使用、氣密、不透光的包裝,以保持眼霜的功效。眼藥水市場的蓬勃發展刺激了眼科包裝的創新。
由於眼科疾病盛行率上升、眼科產品出口增加、針對眼科領域的研發投資增加以及參數化包裝嚴格的監管政策,北美將成為預測期內最大的市場佔有率。例如,2023 年 2 月,West Pharmaceutical Services 宣布擴大與康寧目前的合作關係。此次擴張還包括康寧 Valor管瓶的獨家經銷權。它還包括推出該公司的旗艦產品 West Ready Pack,其中包括康寧的 Valor RTU管瓶。
預計亞太地區在預測期內的複合年成長率最高。這是因為需要快速可靠的包裝解決方案,以滿足安全要求、提高患者舒適度、採用防篡改技術並提供優質產品和產品保護。例如,2023年3月,肖特開始在印度生產琥珀色醫用玻璃,以滿足不斷成長的需求。這項措施擴大了印度和亞洲藥品包裝製造商可用的硼矽酸玻璃的範圍。
According to Stratistics MRC, the Global Ophthalmic Packaging Market is accounted for $11.5 billion in 2023 and is expected to reach $23.1 billion by 2030 growing at a CAGR of 10.4% during the forecast period. Ophthalmic packaging plays a crucial role in protecting and delivering sensitive eye medications. These specialized packages are designed with precision and care, considering factors like sterility, accuracy, and ease of use. These are typically sterile and sealed to maintain product efficacy, ophthalmic packaging employs materials that meet regulatory standards. Clear labeling facilitates proper usage instructions, while tamper-evident features enhance consumer confidence. The packaging's ergonomic design prioritizes user convenience, supporting easy dispensing and storage.
According to the USA General Population Cross-sectional Study, 2018, around 16.7 to 50.2 million Americans have a dry eye disease, accounting for 5% to 15% of the total population.
Increase in eye-related disorders and conditions
As the prevalence of ailments like cataracts and glaucoma rises globally, there is an increased demand for specialized packaging that ensures the safety, efficacy, and proper administration of ophthalmic products. This has led to innovations in packaging design, incorporating features like advanced drug delivery systems and tamper-evident measures. The growing need for compliance with stringent regulatory standards and the emphasis on consumer-friendly, convenient packaging further propel the Ophthalmic Packaging market
Limited shelf life
Packaging solutions must ensure product stability and prevent deterioration within a short timeframe, increasing complexity and cost. Manufacturers face challenges in meeting stringent requirements for preserving the efficacy of sensitive formulations. Short shelf life necessitates rapid production and distribution, raising operational costs. Additionally, frequent product turnover places pressure on inventory management. This constraint not only limits the flexibility of packaging design but also hinders cost-effectiveness, impacting profit margins.
Growing awareness among consumers regarding eye health
Increased awareness prompts consumers to prioritize eye care, leading to a surge in demand for ophthalmic products. Consequently, packaging plays a crucial role in attracting and retaining customers by ensuring product safety, efficacy, and convenience. Brands are compelled to invest in visually appealing and informative packaging to communicate the benefits of their eye care products, fostering consumer trust boosting the market growth.
Availability of raw materials with intense competition
Meeting rigorous regulatory requirements demands extensive testing, documentation, and adherence to complex guidelines, escalating development and production costs. Small and medium-sized enterprises may find it particularly burdensome, hindering their entry into the market. The need for continuous updates to comply with evolving regulations further strains resources. Additionally, the stringent standards may limit flexibility and innovation, as companies prioritize meeting compliance over exploring novel packaging solutions hindering the market growth.
Covid-19 Impact
Lockdowns, travel restrictions, and a shift in consumer priorities have caused a decline in demand for non-essential goods, including certain ophthalmic products. Additionally, the focus on healthcare resources for pandemic-related issues has diverted attention from routine eye care. These factors have collectively resulted in a temporary downturn for the Ophthalmic Packaging market
The plastic droptainer bottles segment is expected to be the largest during the forecast period
The plastic droptainer bottles segment is estimated to have a lucrative growth, as these lightweight and durable containers provide a secure environment for ophthalmic solutions, protecting them from contamination and preserving their efficacy. The adoption of plastic droptainer bottles has led to improved user-friendliness and increased shelf life of ophthalmic products. Their cost-effectiveness and ease of manufacturing have also contributed to market growth.
The eye lotions segment is expected to have the highest CAGR during the forecast period
The eye lotions segment is anticipated to witness the highest CAGR growth during the forecast period, as these formulations gain popularity for their therapeutic and cosmetic applications, packaging requirements have evolved. Demand for innovative packaging solutions, ensuring product integrity and user convenience, has surged. Manufacturers are increasingly focusing on creating user-friendly, airtight, and light-protective packaging to preserve the potency of eye lotions. The dynamic growth in the eye lotion segment has consequently stimulated innovation in Ophthalmic Packaging
North America is projected to hold the largest market share during the forecast period owing to the owing to the rising prevalence of ocular disorders, the growing export of ophthalmic products, increasing investment in R&D specific to the ophthalmic field, and stringent regulatory policies in parametrical packaging. For instance, in February 2023, West Pharmaceutical Services announced the expansion of its current collaboration with Corning. This expansion included exclusive rights to distribute Corning Valour glass vials. It also involved launching the company's primary product, West Ready Pack, containing Corning Valour RTU vials.
Asia Pacific is projected to have the highest CAGR over the forecast period, owing to owing to the need for speedy and reliable packaging solutions that fulfil a combination of security requirements, enhance patient comfort, comprise tamper-evident technology, and provide high-quality products and product protection. For instance, in March 2023, SCHOTT launched the production of amber medical glass in India to address rising demand. This initiative extended the availability of borosilicate glass variants to pharma packaging producers in India and Asia.
Key players in the market
Some of the key players in the Ophthalmic Packaging Market include SCHOTT AG, West Pharmaceutical Services, Inc., Mitotech, SA, Akorn, Inc., Santen Pharmaceutical Co., Amcor, Bausch & Lomb Incorporated, Bayer AG, Teva Pharmaceutical Industries Ltd., Gerresheimer AG, Novartis AG, ALLERGAN, Johnson & Johnson Vision, AptarGroup, Inc., F. Hoffmann-La Roche Ltd., Aerie Pharmaceuticals, INC and Merck Sharp & Dohme Corp.
In November 2023, Amcor and NOVA Chemicals announce agreement to source mechanically recycled polyethylene. Increasing the use of rPE in flexible packaging applications is an important element of Amcor's commitment to support packaging circularity.
In July 2023, Santen Agrees to License Agreements and Asset Transfer for its Pharmaceutical Products in North America. Under the terms of the agreement, Santen grants Visiox exclusive rights in the U.S. for product manufacturing and commercialization of OMLONTI?. Santen is eligible to receive sales milestone payments, as well as royalties on net U.S. sales of OMLONTI?.
In July 2022, Mitotech S.A, announced entering a partnership agreement with Essex Bio-Investment for Phase 3 clinical program in Dry Eye Disease. Mitotech S.A, a Luxembourg based clinical stage biotechnology company, announced entering a partnership agreement with Essex Bio-Investment for Phase 3 clinical program.
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.